|
| Press Releases |
|
 |
|
| Thursday, October 17, 2024 |
|
|
Athos宣佈其人工智慧生成的全新口服G9A抑製劑ATH-063的I期臨床試驗頂線數據，顯示其對強效抗炎調節性T細胞的選擇性擴增和啟動 |
| Athos Therapeutics, Inc.（“Athos”），一家處於臨床階段的生物技術公司，致力於為免疫介導疾病患者開發精準的小分子療法，今天宣布了公司I期臨床試驗的頂線結果。該試驗涉及ATH-063，這是一種正在開發中的口服小分子G9A抑制劑，也是公司為治療炎症性腸病（IBD）開發的主要資產。 more info >> |
|
|
Athos宣布其人工智能生成的全新口服G9A抑制剂ATH-063的I期临床试验顶线数据，显示其对强效抗炎调节性T细胞的选择性扩增和激活 |
| Athos Therapeutics, Inc.（“Athos”），一家处于临床阶段的生物技术公司，致力于为免疫介导疾病患者开发精准的小分子疗法，今天宣布了公司I期临床试验的顶线结果。该试验涉及ATH-063，这是一种正在开发中的口服小分子G9A抑制剂，也是公司为治疗炎症性肠病（IBD）开发的主要资产。 more info >> |
|
|
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells |
| Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of precision small molecule therapeutics for patients with immune-mediated diseases, today announced topline results for the company's Phase 1 clinical trial of ATH-063, an investigational oral small molecule G9A inhibitor and the company's lead asset in development for the treatment of inflammatory bowel disease (IBD). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
SAP發布「自主營運企業」願景
May 13, 2026 14:56 HKT/SGT
|
|
|
SAP Unveils the Autonomous Enterprise
May 13, 2026 14:32 HKT/SGT
|
|
|
LEXUS、「LBX MORIZO RR」を一部改良
May 13, 2026 13:45: JST
|
|
|
阿格妮特·柯克·克里斯蒂安森獲任命為樂高基金會主席
May 13, 2026 13:35 HKT/SGT
|
|
|
阿格妮特·柯克·克里斯蒂安森被任命为乐高基金会主席
May 13, 2026 13:35 HKT/SGT
|
|
|
Agnete Kirk Kristiansen Appointed Chair of the LEGO Foundation
May 13, 2026 13:35 HKT/SGT
|
|
|
Nissin Foods Announces 2026 Q1 Financial Results
May 13, 2026 12:43 HKT/SGT
|
|
|
日清食品公佈2026年首季度業績
May 13, 2026 12:43 HKT/SGT
|
|
|
日清食品公布2026年首季度业绩
May 13, 2026 12:43 HKT/SGT
|
|
|
Anytime Fitness Accelerates Asia-Pacific Expansion
May 13, 2026 10:13 HKT/SGT
|
|
|
Ansons' and POSCO Holdings' Boards Approve Terms for Binding Agreement for DLE Demonstration Plant at Green River
May 13, 2026 09:35: JST
|
|
|
梁瑞安博士受邀出席英国2026 LifeArc转化科学峰会
May 13, 2026 09:17 HKT/SGT
|
|
|
Dr. Shui On Leung Invited to the 2026 LifeArc Translational Science Summit in the UK
May 13, 2026 09:06 HKT/SGT
|
|
|
Ansons' and POSCO Holdings' Boards Approve Terms for Binding Agreement for DLE Demonstration Plant at Green River
May 13, 2026 08:35 HKT/SGT
|
|
|
Redington MD and Group CEO V.S. Hariharan Appointed to GTDC Executive Committee
May 12, 2026 21:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
